Lamivudine (Compound)

Synonyms:lamivudine, 134678-17-4, Epivir, Zeffix, Heptovir, Epivir-HBV, BCH-189, Heptodin, 3TC, 4-amino-1-((2R,5S)-2-(hydroxymethyl)-1,3-oxathiolan-5-yl)pyrimidin-2(1H)-one, (-)-2'-Deoxy-3'-thiacytidine, 2',3'-Dideoxy-3'-thiacytidine, 136891-12-8, 3'-Thia-2',3'-dideoxycytidine, GR109714X, GR-109714X, (-)-BCH-189, beta-L-2',3'-Dideoxy-3'-thiacytidine, beta-L-3'-Thia-2',3'-dideoxycytidine, 4-amino-1-[(2R,5S)-2-(hydroxymethyl)-1,3-oxathiolan-5-yl]pyrimidin-2-one, (-)NGPB-21, GR 109714X, UNII-2T8Q726O95, BCH 189, (-)-, 4-AMINO-1-[(2R,5S)-2-(HYDROXYMETHYL)-1,3-OXATHIOLAN-5-YL]-1,2-DIHYDROPYRIMIDIN-2-ONE, Hepitec, (-)-1-((2R,5S)-2-(Hydroxymethyl)-1,3-oxathiolan-5-yl)cytosine, 4-amino-1-[(2R,5S)-2-(hydroxymethyl)-1,3-oxathiolan-5-yl]pyrimidin-2(1H)-one, 4-AMINO-1-[(2R,5S)-2-(HYDROXYMETHYL)-1,3-OXATHIOLAN-5-YL]-2(1H)-PYRIMIDINONE, CHEBI:63577, (-)-1-[(2R,5S)-2-(Hydroxymethyl)-1,3-oxathiolan-5-yl]cytosine, 4-Amino-1-((2R,5S)-2-(hydroxymethyl)-1,3-oxathiolan-5-yl)-2(1H)-pyrimidinone, MFCD00869739, 2T8Q726O95, Heptivir, Lamivir, Zefix, BCH 189, Lamivudine [USAN:BAN:INN], 4-Amino-1-(cis-2-(hydroxymethyl)-1,3-oxathiolan-5-yl)pyrimidin-2(1H)-one, (-)-(2'R,5'S)-1-[2'-Hydroxymethyl-5'-(1,3-oxathiolanyl)]cytosine, Epivir(TM), HHA & Lamivudine, Lamivudine & GNA, SMR000466319, Epivir (TN), (-)-BCH 189, DTHC, CHEMBL141, HSDB 7155, DRG-0126, 3TC and NV-01, (-)-SddC, Lamivudeine, Lamivudine (JAN/USP/INN), 3TC & GNA, 3TC & SST, HHA & 3TC, (+/-)-SddC, CCRIS 9274, NSC620753, BCH-790, Lamivudine [USAN:USP:INN:BAN], rac-cis-Lamivudine, NCGC00159341-04, Lamivudine- Bio-X, GG-714, Lamivudine (EPIVIR), CPD000466319, (+/-)-3TC, (+/-)-BCH-189, 2(1H)-Pyrimidinone, 4-amino-1-(2-(hydroxymethyl)-1,3-oxathiolan-5-yl)-, (2R-cis)-, MLS000759424, MLS001424097, MLS006011910, BIDD:GT0033, SCHEMBL109675, AMY384, ZINC12346, HMS2051D21, HMS3259F08, HMS3713C16, HY-B0250, BBL033871, BDBM50366817, MFCD00870542, s1706, STK801940, lamivudine & TNF-alpha & IFN-gamma, AKOS005622556, AKOS015854841, Lamivudine, >=98% (HPLC), powder, (-)-BCH189, AC-1416, CCG-100984, DB00709, KS-1073, MCULE-2096184994, NC00234, NC00705

Pubchem:PUBCHEM:60825

Id:60825

Description:nan

Analyze

CFDE DD-Knowledge Graph

The CFDE Data Distillery Knowledge Graph contains entities and relationships across the CFDE. View Lamivudine's neighborhood in the knowledge graph.

Submit

GDLPA Landing Pages Links

The Gene and Drug Landing Page Aggregator (GDLPA) finds links to primary and secondary source information from CFDE and other resources. Discover landing pages for Lamivudine.

Submit

Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with Lamivudine.

Results found

Linked to

	Label	Description
	BRD-K02992638-001-11-8 Substance (Entity type)	A Substance
	lamivudine (090ca5df-33cc-440e-8f65-083b4c53f570) Collection (Entity type)	Metadatata for lamivudine
	DCSTRUCT ID 01539 Collection (Entity type)	DrugPage Collection: (DrugCentralID:01539; PubChem_CID:60825, FILE=drugcentral_drug_01539.json)
	Lamivudine positively regulates BBOX1 Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	Lamivudine in similarity relationship with Urea Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	Lamivudine positively regulates MT1E Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	Lamivudine in similarity relationship with actarit Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	Lamivudine positively regulates CRABP1 Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	Lamivudine negatively regulates LEF1 Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	Lamivudine positively regulates TMEM176B Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS